Moderate-to-Severe Atopic Dermatitis: Expert Insights on Late-Breaking Data in Systemic Treatment - a podcast by ReachMD

CME credits: 0.25

Valid until: 01-10-2021

Claim your CME credit at https://reachmd.com/programs/cme/moderate-to-severe-atopic-dermatitis-expert-insights-on-late-breaking-data-in-systemic-treatment/11796/

Statment of Need
Recent investigations into the underlying mechanisms of atopic dermatitis have revealed the importance of the JAK/STAT pathway and downstream cytokines in driving inflammatory response and AD pathogenesis and have informed the recent development of novel targeted agents. The recent and rapid emergence of new data on novel targeted treatments for moderate-to-severe AD creates a knowledge gap for dermatologists and allergists. As emerging targeted therapies have the potential to become available relatively quickly, dermatologists and allergists must be familiar with the practical considerations associated with using these agents so that they are prepared to integrate these agents into the management of patients with moderate-to-severe AD in a safe and appropriate manner. This activity will bridge the knowledge gap by providing expert perspective on the translation of these data into clinical practice to optimize patient outcomes.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD